Intercure Ltd.
Close on Oct 19, 2026
About Intercure
Pharmaceutical Preparations, SIC 2834
InterCure Ltd. is an Israel-based company operating primarily within the cannabis and biomed segments. The company engages in the research, production, manufacturing, distribution, export, and import of pharmaceutical-grade medical cannabis and cannabis-based medical products. Through its cultivation sites and commercial channels, InterCure supplies and distributes products to medical patients, pharmacies, and external distribution partners across regulated markets.
The company operates cultivation and processing facilities situated in northern and southern Israel, while also pursuing expansion across the European Union, the United States, and Canada. In addition to its cultivation and manufacturing sites, InterCure operates an expanding retail pharmacy chain and maintains commercial distribution networks. InterCure conducts its primary administrative operations from its corporate headquarters and principal executive offices located in Herzliya, Israel.
Summary of the business section of Intercure's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Intercure Ltd.
- Headquarters
- Herzliya, L3
- Address
- 85 Medinat Ha-Yehudim Street 4676670
- Phone
- 972774605012
- Website
- intercure.co
- Industry
- Pharmaceutical Preparations
- Incorporated in
- L3
- Fiscal year ends
- December 31
- Auditor
- Somekh Chaikin, Tel-Aviv, Israel
Stock & identifiers
- Ticker
- INCR
- Exchange
- Nasdaq
- IPO date
- Jan 28, 2019
- Shares outstanding
- 55M, Dec 31, 2025
- Filer category
- Non-accelerated filer<br>Emerging growth company
- Stock splits
- 1-for-5 reverse, Aug 24, 2026
- SEC CIK
- 1857030
- CUSIP
- M549GJ111
- ISIN
- USM549GJ1116
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Alexander Rabinovich | Chief Executive Officer, Director | 14,755,062 |
| Amos Cohen | Chief Financial Officer | 79,947 |
| Alon Shmuel Granot | Director | – |
| Lennie Grinbaum Michelson | Director | 6,743 |
| David Salton | Director | – |
| Gideon Hirschfeld | Director | – |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| May 1, 2025 | Late filing | Notification of late filing |
| May 1, 2024 | Late filing | Notification of late filing |